PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30334187-1	2019	Parkinson"s disease (PD) is a alpha-synucleinopathy in which intracellular aggregates of alpha-synuclein (alpha-syn) result in neurodegeneration and in the impairment of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex-mediated release of neurotransmitters.	Ethylmaleimide	182-198	synuclein alpha	Homo sapiens	30-45	
34705229-4	2022	However, the soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNARE) requirement and vesicle identity of alpha-syn secretion remain elusive.	Ethylmaleimide	21-37	synuclein alpha	Homo sapiens	128-137	
30334187-1	2019	Parkinson"s disease (PD) is a alpha-synucleinopathy in which intracellular aggregates of alpha-synuclein (alpha-syn) result in neurodegeneration and in the impairment of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex-mediated release of neurotransmitters.	Ethylmaleimide	182-198	synuclein alpha	Homo sapiens	30-39	
23197711-2	2012	alphaSyn is involved in the regulation of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex.	Ethylmaleimide	50-66	synuclein alpha	Homo sapiens	0-8	
22936307-5	2013	Normally, alphaSyn protein localizes to presynaptic terminals of neuronal cells, regulating the neurotransmitter release through the modulation of assembly of soluble N-ethylmaleimide-sensitive factor attachment protein receptor complex.	Ethylmaleimide	167-183	synuclein alpha	Homo sapiens	10-18